| 251 |
IVVDInvivyd, Inc. |
Life Sciences |
0.52 |
$190M |
Unlock rating and forecasts |
| 252 |
ELDNEledon Pharmaceuticals, Inc. |
Life Sciences |
0.00 |
$190M |
Unlock rating and forecasts |
| 253 |
TRDAEntrada Therapeutics, Inc. |
Life Sciences |
0.20 |
$189M |
Unlock rating and forecasts |
| 254 |
CGENCOMPUGEN LTD |
Life Sciences |
0.43 |
$187M |
Neutral |
+1.02% |
+3.19% |
· |
| 255 |
LYELLyell Immunopharma, Inc. |
Life Sciences |
0.16 |
$184M |
Unlock rating and forecasts |
| 256 |
STROSUTRO BIOPHARMA, INC. |
Life Sciences |
0.59 |
$183M |
Unlock rating and forecasts |
| 257 |
ORMPORAMED PHARMACEUTICALS INC. |
Life Sciences |
0.11 |
$173M |
Neutral |
+0.90% |
+3.79% |
· |
| 258 |
PEPGPepGen Inc. |
Life Sciences |
0.38 |
$173M |
Neutral |
+1.10% |
+2.48% |
▼ 1 |
| 259 |
ZNTLZentalis Pharmaceuticals, Inc. |
Life Sciences |
0.31 |
$172M |
Unlock rating and forecasts |
| 260 |
CHRSCoherus Oncology, Inc. |
Life Sciences |
0.15 |
$165M |
Unlock rating and forecasts |
| 261 |
MDWDMediWound Ltd. |
Life Sciences |
0.26 |
$157M |
Unlock rating and forecasts |
| 262 |
ORGOOrganogenesis Holdings Inc. |
Life Sciences |
0.37 |
$156M |
Unlock rating and forecasts |
| 263 |
TARAProtara Therapeutics, Inc. |
Life Sciences |
0.17 |
$155M |
Unlock rating and forecasts |
| 264 |
CMPXCompass Therapeutics, Inc. |
Life Sciences |
0.30 |
$154M |
Unlock rating and forecasts |
| 265 |
PYXSPyxis Oncology, Inc. |
Life Sciences |
0.05 |
$154M |
Unlock rating and forecasts |
| 266 |
NKTXNkarta, Inc. |
Life Sciences |
0.26 |
$150M |
Unlock rating and forecasts |
| 267 |
MOLNMOLECULAR PARTNERS AG |
Life Sciences |
0.03 |
$148M |
Unlock rating and forecasts |
| 268 |
AVXLANAVEX LIFE SCIENCES CORP. |
Life Sciences |
0.04 |
$137M |
Unlock rating and forecasts |
| 269 |
ANTXAN2 Therapeutics, Inc. |
Life Sciences |
0.25 |
$136M |
Unlock rating and forecasts |
| 270 |
ALXOALX ONCOLOGY HOLDINGS INC |
Life Sciences |
0.24 |
$135M |
Unlock rating and forecasts |
| 271 |
ABOSAcumen Pharmaceuticals, Inc. |
Life Sciences |
0.19 |
$131M |
Unlock rating and forecasts |
| 272 |
KRROKorro Bio, Inc. |
Life Sciences |
0.13 |
$130M |
Unlock rating and forecasts |
| 273 |
NERVMinerva Neurosciences, Inc. |
Life Sciences |
0.14 |
$120M |
Unlock rating and forecasts |
| 274 |
NRXPNRX Pharmaceuticals, Inc. |
Life Sciences |
0.01 |
$117M |
Unlock rating and forecasts |
| 275 |
TNYATenaya Therapeutics, Inc. |
Life Sciences |
0.08 |
$117M |
Unlock rating and forecasts |
| 276 |
GNLXGENELUX Corp |
Life Sciences |
0.32 |
$114M |
Unlock rating and forecasts |
| 277 |
IFRXInflaRx N.V. |
Life Sciences |
0.22 |
$112M |
Unlock rating and forecasts |
| 278 |
CLLSCellectis S.A. |
Life Sciences |
0.13 |
$110M |
Unlock rating and forecasts |
| 279 |
FHTXFoghorn Therapeutics Inc. |
Life Sciences |
0.13 |
$110M |
Unlock rating and forecasts |
| 280 |
ENGNenGene Therapeutics Inc. |
Life Sciences |
0.42 |
$109M |
Unlock rating and forecasts |
| 281 |
MSLESatellos Bioscience Inc. |
Life Sciences |
0.37 |
$109M |
Neutral |
+0.95% |
+2.42% |
· |
| 282 |
CPIXCUMBERLAND PHARMACEUTICALS INC |
Life Sciences |
0.43 |
$107M |
Unlock rating and forecasts |
| 283 |
LENZLENZ Therapeutics, Inc. |
Life Sciences |
0.58 |
$107M |
Neutral |
+0.98% |
+2.69% |
· |
| 284 |
UNCYUnicycive Therapeutics, Inc. |
Life Sciences |
0.12 |
$104M |
Unlock rating and forecasts |
| 285 |
INOINOVIO PHARMACEUTICALS, INC. |
Life Sciences |
0.23 |
$103M |
Unlock rating and forecasts |
| 286 |
RANIRani Therapeutics Holdings, Inc. |
Life Sciences |
0.21 |
$102M |
Unlock rating and forecasts |